Company Overview of Theregen, Inc.
Theregen, Inc., a regenerative medicine company, develops cell-based therapies for cardiovascular indications. It offers Anginera, an epicardial patch and cell-based therapy for cardiac applications. Theregen, Inc. was formerly known as IKEN Tissue Therapeutics, Inc. The company was founded in 2003 and is based in San Francisco, California.
225 Bush Street
San Francisco, CA 94104
Founded in 2003
Key Executives for Theregen, Inc.
Similar Private Companies By Industry
|Seragen, Inc.||United States|
|Nutriceutical Resources, Inc.||United States|
|Eleos, Inc.||United States|
|Cureline Clinical Consulting Partners||United States|
|Maxim Biotech, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Greater Houston Partnership||United States|
Post a JobJobs
- New York City, NY | InformaticaPosted: Feb 20
- Santa Monica, CA | AstellasPosted: Mar 10
- Parsippany, NJ | RGPPosted: Mar 05
- Deerfield, IL | Takeda Pharmaceuticals North AmericaPosted: Feb 22
Sponsored Financial Commentaries
To contact Theregen, Inc., please visit www.theregen.com. Company data is provided by Capital IQ. Please use this form to report any data issues.